These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35257419)

  • 1. The expression and significance of p4E-BP1/4E-BP1 in prostate cancer.
    Wang KY; Wang KJ; Ma Q
    J Clin Lab Anal; 2022 Apr; 36(4):e24332. PubMed ID: 35257419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. eIF4E activation is commonly elevated in advanced human prostate cancers and significantly related to reduced patient survival.
    Graff JR; Konicek BW; Lynch RL; Dumstorf CA; Dowless MS; McNulty AM; Parsons SH; Brail LH; Colligan BM; Koop JW; Hurst BM; Deddens JA; Neubauer BL; Stancato LF; Carter HW; Douglass LE; Carter JH
    Cancer Res; 2009 May; 69(9):3866-73. PubMed ID: 19383915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancer.
    Millican-Slater RA; Sayers CD; Hanby AM; Hughes TA
    Br J Cancer; 2016 Jul; 115(3):339-45. PubMed ID: 27280636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Activation Status of the Akt/mTOR Signalling Pathway on the Clinical Behaviour of Synovial Sarcoma: Retrospective Analysis of 174 Patients at a Single Institution.
    Li YX; Ding SS; Wen WJ; Han L; Wang HQ; Shi HY
    Cancer Manag Res; 2020; 12():1759-1769. PubMed ID: 32210617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells.
    Nishi T; Iwasaki K; Ohashi N; Tanaka C; Kobayashi D; Nakayama G; Koike M; Fujiwara M; Kobayashi T; Kodera Y
    Cancer Lett; 2013 May; 331(2):220-9. PubMed ID: 23340172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity is associated with higher 4E-BP1 expression in endometrial cancer.
    Libby EF; Azrad M; Novak L; Vazquez AI; Wilson TR; Demark-Wahnefried W
    Curr Biomark Find; 2014 Jan; 2014(4):1-7. PubMed ID: 24639918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibiting eukaryotic initiation factor 5A (eIF5A) hypusination attenuated activation of the SIK2 (salt-inducible kinase 2)-p4E-BP1 pathway involved in ovarian cancer cell proliferation and migration.
    Lee GK; Kim HY; Park JH
    Mol Biol Rep; 2023 Jul; 50(7):5807-5816. PubMed ID: 37219665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phospho-4e-BP1 and eIF4E overexpression synergistically drives disease progression in clinically confined clear cell renal cell carcinoma.
    Campbell L; Jasani B; Griffiths DF; Gumbleton M
    Am J Cancer Res; 2015; 5(9):2838-48. PubMed ID: 26609489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PC-1/PrLZ confers resistance to rapamycin in prostate cancer cells through increased 4E-BP1 stability.
    Yu L; Shang ZF; Wang J; Wang H; Huang F; Zhang Z; Wang Y; Zhou J; Li S
    Oncotarget; 2015 Aug; 6(24):20356-69. PubMed ID: 26011939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylated 4E-BP1 is associated with tumor progression and adverse prognosis in colorectal cancer.
    Chen Y; Wang J; Fan H; Xie J; Xu L; Zhou B
    Neoplasma; 2017; 64(5):787-794. PubMed ID: 28592131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
    Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
    Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of the activation status of the Akt/mTOR pathway in synovial sarcoma.
    Setsu N; Kohashi K; Fushimi F; Endo M; Yamamoto H; Takahashi Y; Yamada Y; Ishii T; Yokoyama K; Iwamoto Y; Oda Y
    Cancer; 2013 Oct; 119(19):3504-13. PubMed ID: 23861137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of phosphorylated 4E-BP1 predicts for tumor recurrence and reduced survival in cervical carcinoma treated with postoperative radiotherapy.
    Benavente S; Vergés R; Hermosilla E; Fumanal V; Casanova N; García A; Ramón Y Cajal S; Giralt J
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1316-22. PubMed ID: 19362787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics.
    Dai B; Kong YY; Ye DW; Ma CG; Zhou X; Yao XD
    BJU Int; 2009 Oct; 104(7):1009-16. PubMed ID: 19389013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of GOLPH3 associated with the progression of gastric cancer: a preliminary study.
    Peng J; Fang Y; Tao Y; Li K; Su T; Nong Y; Xie F; Lai M
    PLoS One; 2014; 9(10):e107362. PubMed ID: 25286393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrations in translational regulation are associated with poor prognosis in hormone receptor-positive breast cancer.
    Meric-Bernstam F; Chen H; Akcakanat A; Do KA; Lluch A; Hennessy BT; Hortobagyi GN; Mills GB; Gonzalez-Angulo A
    Breast Cancer Res; 2012 Oct; 14(5):R138. PubMed ID: 23102376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbon Nanospheres Exert Antitumor Effects Associated with Downregulation of 4E-BP1 Expression on Prostate Cancer.
    Dong W; Luo Y; Zhang G; Zhang H; Liang Y; Zhuo Y; Liang Y; Zou F; Zhong W
    Int J Nanomedicine; 2020; 15():5545-5559. PubMed ID: 32848387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer.
    Lee HW; Park MI; Kim MS; Kim SH; Roh MS; Kim K; Jung SB; Lee EH
    Pathol Res Pract; 2015 Apr; 211(4):298-302. PubMed ID: 25661069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression level of phosphorylated-4E-binding protein 1 in radical nephrectomy specimens as a prognostic predictor in patients with metastatic renal cell carcinoma treated with mammalian target of rapamycin inhibitors.
    Nishikawa M; Miyake H; Harada K; Fujisawa M
    Med Oncol; 2014 Jan; 31(1):792. PubMed ID: 24307346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and phosphorylation of eukaryotic translation initiation factor 4E binding protein 1 in B-cell lymphomas and reactive lymphoid tissues.
    Kodali D; Rawal A; Ninan MJ; Patel MR; Mesa H; Knapp D; Schnitzer B; Kratzke RA; Gupta P
    Arch Pathol Lab Med; 2011 Mar; 135(3):365-71. PubMed ID: 21366462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.